Greg Everson

Greg EversonGreg Everson, M.D., FACP
CEO, Inventor, Founder & Manager

 

Dr. Everson is currently Professor of Medicine and Director, Section of Hepatology in the Division of Gastroenterology at the University of Colorado School of Medicine in Denver, CO. He is the inventor of the HepQuant tests and technology, Founder of HepQuant LLC, and in conjunction with the Technology Transfer Office of the University of Colorado has filed intellectual property rights in the US, EU, Canada, and Australia related to this testing and technology.

 

 

Dr. Everson received his MD degree from Cornell Medical College, New York, NY, trained in Internal Medicine at Creighton University, Omaha, NE, trained in Gastroenterology/Hepatology at the University of Colorado Health Sciences Center, Denver, CO, and is currently a Professor of Medicine and Director of Hepatology at the University of Colorado Denver and University of Colorado Hospital. He has published over 300 original papers, books, and book chapters in peer-reviewed journals that include the New England Journal of Medicine, Lancet, Gastroenterology, Hepatology, and Journal of Hepatology. He has co-authored 5 editions of the popular “self-help” book, Living with Hepatitis C: A Survivor’s Guide, 2 editions of Living with Hepatitis B: A Survivor’s Guide, and Living with Hemochromatosis: Expert Answers to Your Questions about Iron Overload. He recently published as sole author, Curing Hepatitis C: Current and Future Options for Treatment. Dr. Everson is a frequently invited speaker and has presented his work at clinical and scientific meetings nationally and internationally. He has been a principal investigator for many NIH (National Institutes of Health)- and Industry-sponsored research studies and clinical trials.

 

Dr. Everson is a distinguished fellow of the American College of Physicians (ACP), and the American Gastroenterological Association (AGA). He is a member of the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), the American Society of Transplantation (AST), the International Liver Transplant Society (ILTS), and the International Association for the Study of the Liver (IASL). He is a former member of the Transplant Hepatology Committee of the American Board of Internal Medicine and current board member of the Ad Hoc Transplant Hepatology Committee of the Accreditation Council for Graduate Medical Education.